{"entity":{"id":"kemu-lahore","kind":"institution","name":"King Edward Medical University and Mayo Hospital, Lahore","aka":["KEMU","King Edward Medical University","Mayo Hospital Lahore"],"tldr":"A medical university in Lahore whose teaching hospital, Mayo Hospital, has a radiotherapy and oncology department that runs academic trials such as a gentler schedule of salvage chemotherapy for lymphoma.","summary":"King Edward Medical University is a medical university in Lahore; its website lists a Radiotherapy and Oncology department among its clinical units. Its teaching hospital is Mayo Hospital. The university sponsors NCT07739654, a randomised phase 3 trial at Mayo Hospital, led by Abbas Khokhar, Professor of Medical Oncology and Radiotherapy, comparing a modified DHAP schedule (cisplatin 50 mg/m2 over six hours on days 1 and 2, cytarabine 2 g/m2 on days 1 and 2) with the standard schedule in 74 adults with relapsed or refractory diffuse large B-cell lymphoma, with overall response rate as the primary endpoint and the aim of reducing kidney toxicity and allowing outpatient treatment. The map position is the city centre.","asOf":"2026-11-04","links":[{"label":"King Edward Medical University","url":"https://kemu.edu.pk/"},{"label":"ClinicalTrials.gov NCT07739654","url":"https://clinicaltrials.gov/study/NCT07739654"}],"tags":[],"related":[],"cancers":["dlbcl"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct07739654"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Lahore","country":"PK","lat":31.558,"lng":74.35071,"institutionType":"university","website":"https://kemu.edu.pk/","programs":["Radiotherapy and Oncology department, Mayo Hospital","Undergraduate and postgraduate medical education"]},"route":"/institutions/kemu-lahore/","neighbours":{"cancer":[{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"}],"trial":[{"id":"nct07739654","kind":"trial","name":"Modified against standard DHAP salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma (Lahore)","route":"/trials/nct07739654/"}]}}